Search research articles
Contact Us
Filters
Showing results (1-10 of 159) with videos related to
Page
of 16
Sort By:
Annals of Internal Medicine
|
May 22, 2002
Anorexogen-related cardiac valvulopathy
Richard B Rothman
American Journal of Therapeutics
|
April 9, 2009
Treatment of obesity with "combination" pharmacotherapy
Richard B Rothman
The Neurologist
|
April 19, 2015
The case of posterior reversible encephalopathy with intracranial hemorrhage was likely due to uncontrolled hypertension, and was unrelated and coincidental to long-term phentermine use
Ed J Hendricks, Richard B Rothman
International Journal of Cardiology
|
March 9, 2010
Phentermine cardiovascular safety II: response to Yosefy Int J Cardiol. 2009 Epub Mar 19
Richard B Rothman, Ed J Hendricks
Pharmacology & Therapeutics
|
August 7, 2002
Therapeutic and adverse actions of serotonin transporter substrates
Richard B Rothman, Michael H Baumann
Pharmacology, Biochemistry, and Behavior
|
March 13, 2002
Serotonin releasing agents. Neurochemical, therapeutic and adverse effects
Richard B Rothman, Michael H Baumann
Annals of the New York Academy of Sciences
|
November 16, 2006
Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs
Richard B Rothman, Michael H Baumann
American Journal of Therapeutics
|
December 19, 2008
Appetite suppressants, cardiac valve disease and combination pharmacotherapy
Richard B Rothman, Michael H Baumann
Expert Opinion on Drug Safety
|
June 10, 2009
Serotonergic drugs and valvular heart disease
Richard B Rothman, Michael H Baumann
International Journal of Cardiology
|
February 5, 2009
Phentermine cardiovascular safety. In response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine. International journal of cardiology 2006;106:262-3
Richard B Rothman, Ed J Hendricks
Page
of 16
Search research articles
Search
Showing results (1-10 of 159) with videos related to
Sort By:
Page
of 16
Annals of Internal Medicine
|
May 22, 2002
Anorexogen-related cardiac valvulopathy
Richard B Rothman
American Journal of Therapeutics
|
April 9, 2009
Treatment of obesity with "combination" pharmacotherapy
Richard B Rothman
The Neurologist
|
April 19, 2015
The case of posterior reversible encephalopathy with intracranial hemorrhage was likely due to uncontrolled hypertension, and was unrelated and coincidental to long-term phentermine use
Ed J Hendricks, Richard B Rothman
International Journal of Cardiology
|
March 9, 2010
Phentermine cardiovascular safety II: response to Yosefy Int J Cardiol. 2009 Epub Mar 19
Richard B Rothman, Ed J Hendricks
Pharmacology & Therapeutics
|
August 7, 2002
Therapeutic and adverse actions of serotonin transporter substrates
Richard B Rothman, Michael H Baumann
Pharmacology, Biochemistry, and Behavior
|
March 13, 2002
Serotonin releasing agents. Neurochemical, therapeutic and adverse effects
Richard B Rothman, Michael H Baumann
Annals of the New York Academy of Sciences
|
November 16, 2006
Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs
Richard B Rothman, Michael H Baumann
American Journal of Therapeutics
|
December 19, 2008
Appetite suppressants, cardiac valve disease and combination pharmacotherapy
Richard B Rothman, Michael H Baumann
Expert Opinion on Drug Safety
|
June 10, 2009
Serotonergic drugs and valvular heart disease
Richard B Rothman, Michael H Baumann
International Journal of Cardiology
|
February 5, 2009
Phentermine cardiovascular safety. In response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine. International journal of cardiology 2006;106:262-3
Richard B Rothman, Ed J Hendricks
Page
of 16